Safety and tolerability of calcipotriol in psoriasis.
D002117:Calcitriol / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000378:metabolism; D002118:Calcium / Q000378:metabolism; D003879:Dermatologic Agents / Q000009:adverse effects* / Q000378:metabolism; D003875:Drug Eruptions / Q000209:etiology*; D006801:Humans; D011565:Psoriasis / Q000188:drug therapy* / Q000378:metabolism
D003879:Dermatologic Agents; C055085:calcipotriene; D002117:Calcitriol; D002118:Calcium